Make an Appointment
-
Memorial Pediatric Group1275 York Avenue, New York, NY 10065 map
Dr. Christopher Forlenza is a hematologist / oncologist in New York. He is a cancer specialist trained in blood disorders and the medical treatment of malignancies.
Memorial Pediatric Group
Accepting New Patients?
Yes, Dr. Christopher J. Forlenza is accepting new patients at this office.
Phone
Address
1275 York Avenue, New York, NY 10065-6007
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Christopher Forlenza graduated from New York University School of Medicine in 2008.
Dr. Forlenza has one office in New York where he specializes in Hematology / Oncology and Pediatrics.
Dr. Forlenza works with twenty-seven doctors including Dr. Nancy Kernan and Dr. Ira Dunkel.
Specialties
-
Hematology / Oncology
As a hematologist / oncologist in New York, Dr. Forlenza is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Forlenza may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Forlenza may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
-
Pediatrics
Dr. Forlenza is a pediatrician, a physician dedicated to helping kids of all age groups. He offers comprehensive health care for newborns, young children & teens. As a pediatrician, Dr. Forlenza is a primary care provider, the first point of contact when a patient is sick. Dr. Forlenza is trained to provide well-rounded health care for children of all ages and works very closely with the patient's parents & family making sure that the child is developing & maturing properly.
Education & Training
Latest Hematology / Oncology News
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
Incontinence Drug May Cut Hot Flashes in Breast Cancer SurvivorsSteven Reinberg, HealthDay Reporter, Dec 7, 2018 at 9:00 AM
-
Healthy Lifestyle Lowers Odds of Breast Cancer's ReturnRobert Preidt, Dec 7, 2018 at 9:00 AM